CPT code 82128 designates a laboratory procedure for measuring multiple amino acids in specimens such as blood, plasma, urine, amniotic fluid, or cerebrospinal fluid. This panel-level amino acid analysis is clinically important for diagnosing inborn errors of metabolism, guiding biochemical genetic workups, and informing acute and chronic care pathways for affected patients. Nationally, amino acid testing plays a central role in newborn screening follow-up and in evaluating unexplained metabolic or neurologic symptoms across age groups.

Key payers covered in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find context on clinical indications and typical service settings, an overview of payer coverage considerations, and the operational aspects that influence billing and claims submission for amino acid panels. The publication outlines common modifiers and billing practices, summarizes service line placement within laboratory workflows, and highlights areas where payers commonly apply medical necessity criteria or prior authorization requirements.

The analysis provides benchmarks for utilization and reimbursement patterns, clarifies coding expectations for multi-specimen amino acid testing, and summarizes policy updates that affect laboratory service billing. Data not available in the input is noted where applicable.